A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN | MicrobiomeTrials← Back to trialsNCT04667013
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2028-09-01Est. Completion: 2029-03-31
Enrollment target: 16 participants Other microbiome trials you might be interested in
Periodontal Diseases
Background: Periodontitis is a chronic inflammatory disease characterized by the destruction of tooth-supporting tissues…
Alexandria, EgyptEst. completion Sep 30, 2027
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
The project will evaluate the potential benefit of the use of bone replacement graft as an adjunct to surgical therapy o…
Gothenburg, SwedenEst. completion Mar 14, 2022